Table 2. Sample and comparison limited-hold values for each subject in the last block of trials for Phase II, along with the actual mean latencies at each limited hold.
Subject | Limited-hold values (s) |
Mean latencies (s) |
||
Sample | Comparisons | Sample | Comparisons | |
ALE | 0.50 | 1.30 | 0.25 | 0.71 |
CA | 0.50 | 1.30 | 0.25 | 0.71 |
EMM | 0.40 | 1.20 | 0.28 | 0.59 |
PLRA | 0.40 | 1.20 | 0.26 | 0.73 |
SU | 0.50 | 1.30 | 0.15 | 0.67 |